PL368117A1 - Nowe bezwodne krystaliczne postacie gabapentyny - Google Patents
Nowe bezwodne krystaliczne postacie gabapentynyInfo
- Publication number
- PL368117A1 PL368117A1 PL02368117A PL36811702A PL368117A1 PL 368117 A1 PL368117 A1 PL 368117A1 PL 02368117 A PL02368117 A PL 02368117A PL 36811702 A PL36811702 A PL 36811702A PL 368117 A1 PL368117 A1 PL 368117A1
- Authority
- PL
- Poland
- Prior art keywords
- gabapentin
- crystalline forms
- anhydrous crystalline
- new anhydrous
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32837501P | 2001-10-09 | 2001-10-09 | |
US10/256,155 US6800782B2 (en) | 2001-10-09 | 2002-09-25 | Anhydrous crystalline forms of gabapentin |
PCT/US2002/031706 WO2003031391A1 (en) | 2001-10-09 | 2002-10-03 | New anhydrous crystalline forms of gabapentin |
Publications (1)
Publication Number | Publication Date |
---|---|
PL368117A1 true PL368117A1 (pl) | 2005-03-21 |
Family
ID=26945177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL02368117A PL368117A1 (pl) | 2001-10-09 | 2002-10-03 | Nowe bezwodne krystaliczne postacie gabapentyny |
Country Status (27)
Country | Link |
---|---|
US (1) | US6800782B2 (pl) |
EP (1) | EP1463712A1 (pl) |
JP (1) | JP2005505594A (pl) |
KR (1) | KR20050033525A (pl) |
CN (1) | CN1568305A (pl) |
AP (1) | AP2004003025A0 (pl) |
BG (1) | BG108702A (pl) |
BR (1) | BR0213156A (pl) |
CA (1) | CA2462331A1 (pl) |
CO (1) | CO5570697A2 (pl) |
CZ (1) | CZ2004416A3 (pl) |
EA (1) | EA006557B1 (pl) |
GE (1) | GEP20063936B (pl) |
HR (1) | HRP20040408A2 (pl) |
HU (1) | HUP0401782A3 (pl) |
IL (1) | IL161099A0 (pl) |
IS (1) | IS7195A (pl) |
MA (1) | MA27072A1 (pl) |
MX (1) | MXPA04003301A (pl) |
NO (1) | NO20041370L (pl) |
NZ (1) | NZ531993A (pl) |
OA (1) | OA12665A (pl) |
PL (1) | PL368117A1 (pl) |
RS (1) | RS28204A (pl) |
SK (1) | SK1572004A3 (pl) |
TN (1) | TNSN04055A1 (pl) |
WO (1) | WO2003031391A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070043236A1 (en) * | 2003-05-19 | 2007-02-22 | Chandiran Thakashina M | Process for preparation of gabapentin |
WO2004106281A1 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Crystalline gabapentin |
WO2004110342A2 (en) * | 2003-06-12 | 2004-12-23 | Matrix Laboratories Ltd | Novel polymorph of gabapentin and its conversion to gabapentin form-ii |
US7169812B2 (en) * | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
ITMI20040579A1 (it) * | 2004-03-25 | 2004-06-25 | Zambon Spa | Processo di preparazione di gabapentina |
WO2010023694A2 (en) * | 2008-09-01 | 2010-03-04 | Hikal Ltd | Crystalline forms of gabapentin and process thereof |
CN104649921B (zh) * | 2015-01-14 | 2016-09-28 | 天津大学 | 一种加巴喷丁与己二酸共晶及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
JPS62247160A (ja) * | 1986-03-31 | 1987-10-28 | Aisin Seiki Co Ltd | スタ−リングエンジンの始動装置 |
US4960931A (en) | 1988-05-02 | 1990-10-02 | Warner-Lambert Company | Gabapentin mohohydrate and a process for producing the same |
US4894476A (en) | 1988-05-02 | 1990-01-16 | Warner-Lambert Company | Gabapentin monohydrate and a process for producing the same |
DE3928184A1 (de) | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
IL119890A (en) | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
ES2137137B1 (es) | 1998-05-25 | 2000-08-16 | Medichem Sa | Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. |
-
2002
- 2002-09-25 US US10/256,155 patent/US6800782B2/en not_active Expired - Fee Related
- 2002-10-03 EP EP02766485A patent/EP1463712A1/en not_active Withdrawn
- 2002-10-03 MX MXPA04003301A patent/MXPA04003301A/es active IP Right Grant
- 2002-10-03 CA CA002462331A patent/CA2462331A1/en not_active Abandoned
- 2002-10-03 IL IL16109902A patent/IL161099A0/xx unknown
- 2002-10-03 CN CNA02820056XA patent/CN1568305A/zh active Pending
- 2002-10-03 NZ NZ531993A patent/NZ531993A/en unknown
- 2002-10-03 RS YU28204A patent/RS28204A/sr unknown
- 2002-10-03 CZ CZ2004416A patent/CZ2004416A3/cs unknown
- 2002-10-03 GE GE5594A patent/GEP20063936B/en unknown
- 2002-10-03 JP JP2003534375A patent/JP2005505594A/ja active Pending
- 2002-10-03 BR BR0213156-0A patent/BR0213156A/pt not_active IP Right Cessation
- 2002-10-03 EA EA200400417A patent/EA006557B1/ru not_active IP Right Cessation
- 2002-10-03 AP APAP/P/2004/003025A patent/AP2004003025A0/en unknown
- 2002-10-03 HU HU0401782A patent/HUP0401782A3/hu unknown
- 2002-10-03 SK SK157-2004A patent/SK1572004A3/sk not_active Application Discontinuation
- 2002-10-03 OA OA1200400095A patent/OA12665A/en unknown
- 2002-10-03 KR KR1020047005149A patent/KR20050033525A/ko not_active Application Discontinuation
- 2002-10-03 PL PL02368117A patent/PL368117A1/pl not_active Application Discontinuation
- 2002-10-03 WO PCT/US2002/031706 patent/WO2003031391A1/en active Application Filing
-
2004
- 2004-03-23 IS IS7195A patent/IS7195A/is unknown
- 2004-04-01 NO NO20041370A patent/NO20041370L/no not_active Application Discontinuation
- 2004-04-05 MA MA27606A patent/MA27072A1/fr unknown
- 2004-04-06 CO CO04032599A patent/CO5570697A2/es not_active Application Discontinuation
- 2004-04-07 TN TNP2004000055A patent/TNSN04055A1/fr unknown
- 2004-04-28 BG BG108702A patent/BG108702A/xx unknown
- 2004-05-07 HR HR20040408A patent/HRP20040408A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2462331A1 (en) | 2003-04-17 |
EA200400417A1 (ru) | 2004-10-28 |
IL161099A0 (en) | 2004-08-31 |
NZ531993A (en) | 2006-09-29 |
EA006557B1 (ru) | 2006-02-24 |
NO20041370L (no) | 2004-04-01 |
IS7195A (is) | 2004-03-23 |
JP2005505594A (ja) | 2005-02-24 |
OA12665A (en) | 2006-06-19 |
SK1572004A3 (sk) | 2005-03-04 |
CZ2004416A3 (cs) | 2005-03-16 |
HUP0401782A2 (hu) | 2005-10-28 |
HRP20040408A2 (en) | 2004-10-31 |
CN1568305A (zh) | 2005-01-19 |
GEP20063936B (en) | 2006-10-10 |
BR0213156A (pt) | 2004-09-14 |
RS28204A (en) | 2006-12-15 |
KR20050033525A (ko) | 2005-04-12 |
AP2004003025A0 (en) | 2004-06-30 |
CO5570697A2 (es) | 2005-10-31 |
MXPA04003301A (es) | 2004-07-23 |
EP1463712A1 (en) | 2004-10-06 |
US20030092933A1 (en) | 2003-05-15 |
TNSN04055A1 (fr) | 2006-06-01 |
MA27072A1 (fr) | 2004-12-20 |
US6800782B2 (en) | 2004-10-05 |
HUP0401782A3 (en) | 2006-01-30 |
WO2003031391A1 (en) | 2003-04-17 |
BG108702A (en) | 2005-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070653A1 (en) | Novel crystalline compound | |
ZA200410320B (en) | Crystallization of sugars | |
HUP0500733A3 (en) | Crystallization of igf-1 | |
IL159861A0 (en) | Crystalline forms of fluvastatin sodium | |
PL369102A1 (pl) | Proteza zębowa | |
GB2383038B (en) | Anhydrous crystal form of valaciclovir hydrochloride | |
IL157176A0 (en) | Purification of 2-nitro-4-methylsulphonylbenzoic acid | |
IL161099A0 (en) | New anhydrous crystalline forms of gabapentin | |
GB2407140B (en) | Mounting of tubes | |
PL371427A1 (pl) | Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych | |
PL366980A1 (pl) | Analogi kwasu hydroksyeikozenowego | |
ZA200402519B (en) | New anhydrous crystalline forms of gabapentin. | |
AU148464S (en) | Wristwatch | |
HK1072424A1 (en) | Preparation of an anhydrous quinoline-based inhibitor by crystallization | |
EP1486485A4 (en) | NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS | |
TW543759U (en) | Improved structure for fin of evaporator | |
GB0111083D0 (en) | Formation of small crystals | |
GB0127380D0 (en) | Formation of small crystals | |
GB0108226D0 (en) | Novel crystalline forms | |
AP2002002566A0 (en) | Monohydrate of cis-lithium-cynao-4-Ä3-(cyclopentloxy)-4-methoxyphenylÜ cyclohexanecarboxylate | |
IL166599A (en) | Crystalline solid form of (2s-5z) -2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid | |
SI1537210T1 (sl) | Lazna oligonukleotidna inhibicija ekspresije CD40 | |
GB0106464D0 (en) | Crystalline therapeutic agent | |
GB0200617D0 (en) | Characterisation of analytes | |
GB0217750D0 (en) | New use of diaza-anthracene compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |